ATE187077T1 - Wässrige zubereitung mit verzögerter wirkstofffreigabe - Google Patents

Wässrige zubereitung mit verzögerter wirkstofffreigabe

Info

Publication number
ATE187077T1
ATE187077T1 AT95906743T AT95906743T ATE187077T1 AT E187077 T1 ATE187077 T1 AT E187077T1 AT 95906743 T AT95906743 T AT 95906743T AT 95906743 T AT95906743 T AT 95906743T AT E187077 T1 ATE187077 T1 AT E187077T1
Authority
AT
Austria
Prior art keywords
active ingredients
delayed release
bovine somatotropin
aqueous preparation
circulatory system
Prior art date
Application number
AT95906743T
Other languages
English (en)
Inventor
Michael J Hageman
Margaret L Possert
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE187077T1 publication Critical patent/ATE187077T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95906743T 1994-01-25 1995-01-09 Wässrige zubereitung mit verzögerter wirkstofffreigabe ATE187077T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18657294A 1994-01-25 1994-01-25

Publications (1)

Publication Number Publication Date
ATE187077T1 true ATE187077T1 (de) 1999-12-15

Family

ID=22685468

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906743T ATE187077T1 (de) 1994-01-25 1995-01-09 Wässrige zubereitung mit verzögerter wirkstofffreigabe

Country Status (18)

Country Link
US (2) US6471977B1 (de)
EP (1) EP0741579B1 (de)
JP (1) JPH09508118A (de)
KR (1) KR100355517B1 (de)
CN (1) CN1139385A (de)
AT (1) ATE187077T1 (de)
AU (1) AU699746B2 (de)
CA (1) CA2178610A1 (de)
DE (1) DE69513635T2 (de)
DK (1) DK0741579T3 (de)
ES (1) ES2139881T3 (de)
GR (1) GR3032727T3 (de)
LV (1) LV12627B (de)
MX (1) MX9602943A (de)
NZ (1) NZ278770A (de)
SI (1) SI0741579T1 (de)
WO (1) WO1995019787A1 (de)
ZA (1) ZA949350B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
DE69627706T2 (de) * 1996-01-11 2004-02-05 Pharmacia & Upjohn Co., Kalamazoo Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor
US7319032B2 (en) * 2004-04-22 2008-01-15 Medtox Non-sugar sweeteners for use in test devices
PT4037666T (pt) 2020-12-08 2024-06-25 Ruminant Biotech Corp Ltd Aperfeiçoamentos de dispositivos e métodos para administração de substâncias a animais

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118380A (en) 1977-07-25 1978-10-03 Ayerst, Mckenna & Harrison Limited Decapeptide analogs of somatostatin
US4774091A (en) 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
DE3484584D1 (de) 1983-10-14 1991-06-20 Sumitomo Pharma Injektionen mit verzoegerter abgabe.
KR890002631B1 (ko) 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
US4985404A (en) 1984-10-04 1991-01-15 Monsanto Company Prolonged release of biologically active polypeptides
EP0193917A3 (de) 1985-03-06 1987-09-23 American Cyanamid Company Wasserdispersible und wasserlösliche Polymerzusammensetzungen für parenterale Anwendung
BR8603586A (pt) * 1985-07-30 1987-03-10 Int Minerals & Chem Corp Processo para manter a fluidez de um homonio;processo para efetuar a promocao de crescimento em animais e formulacao promotora de crescimento
US4977140A (en) 1985-08-23 1990-12-11 Eli Lilly And Company Injectable sustained release formulation
US4816568A (en) 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
US4857506A (en) 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4888416A (en) 1987-03-30 1989-12-19 International Minerals & Chemical Corp. Method for stabilizing somatotropins
EP0353045B1 (de) 1988-07-26 1995-11-15 Rutgers, The State University of New Jersey Vorrichtungen und Verfahren zur Wachstumsförderung bei Bratgeflügel
EP0374120A3 (de) 1988-12-13 1991-07-31 Monsanto Company Zusammensetzung mit kontrollierter Wirkstoffabgabe von Polypeptiden
US5015627A (en) 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
US5169834A (en) 1990-11-30 1992-12-08 American Cyanamid Company Compositions and method for reducing vial breakage during lyophilization
US5198422A (en) 1992-06-11 1993-03-30 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation

Also Published As

Publication number Publication date
US6699490B2 (en) 2004-03-02
EP0741579A1 (de) 1996-11-13
SI0741579T1 (en) 2000-04-30
NZ278770A (en) 1997-09-22
WO1995019787A1 (en) 1995-07-27
KR100355517B1 (ko) 2003-03-04
DE69513635T2 (de) 2000-05-31
LV12627A (lv) 2001-03-20
US6471977B1 (en) 2002-10-29
AU1521395A (en) 1995-08-08
DK0741579T3 (da) 2000-05-15
GR3032727T3 (en) 2000-06-30
JPH09508118A (ja) 1997-08-19
AU699746B2 (en) 1998-12-10
CA2178610A1 (en) 1995-07-27
ZA949350B (en) 1996-05-24
MX9602943A (es) 1997-06-28
ES2139881T3 (es) 2000-02-16
US20030220242A9 (en) 2003-11-27
CN1139385A (zh) 1997-01-01
US20030092625A1 (en) 2003-05-15
DE69513635D1 (de) 2000-01-05
LV12627B (en) 2001-08-20
EP0741579B1 (de) 1999-12-01

Similar Documents

Publication Publication Date Title
ATE204467T1 (de) Orale darreichungsform
KR890014131A (ko) 생물학적 활성 폴리펩티드의 질내 투여
BR8801242A (pt) Processo de preparar uma composicao para fornecer uma quantidade efetiva de uma dose constante de um ingrediente ativo a um animal e a respectiva composicao
EP0253887A1 (de) Schwache interferondosierung für die erhöhung der impfstoffwirksamkeit.
KR890012668A (ko) 소마토트로핀을 지속적으로 분비시키는 방법
BR8603315A (pt) Processo para produzir um implante de liberacao controlada;implante usado no processo;processo para purificar e concentrar hormonio de crescimento biologicamente ativo em uma forma adequada para incorporacao em um implante para administracao subcutanea
RU98117135A (ru) Композиция стабилизированного гормона роста и способ ее приготовления
DK0518989T3 (da) Parasiticide præparater og fremgangsmåder til fremstilling og anvendelse deraf
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
EE9900428A (et) Köhavastased ravimkoostised
ES2114851T3 (es) Utilizacion de composiciones de liberacion sostenida que contienen gnrh, lhrh o derivados de las mismas.
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
EP0420979A4 (de) Mittel zur verbesserung des fettabbaus und verfahren zur verwendung.
DE69627706D1 (de) Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor
DE69513635D1 (de) Wässrige zubereitung mit verzögerter wirkstofffreigabe
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
KR860006982A (ko) 안정한 감마 인터페론 제형의 제조방법
DK78487D0 (da) Farmaceutisk praeparat indeholdende et i vand kvaeldende polymermateriale
GR3029319T3 (en) Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
JPS6429317A (en) Local administration composition for treating fungal infection
WO1998029131A3 (en) Aqueous glycerol formulations of somatotropin
Lopez-Quijada Failure of iodoacetate to protect the antigenic power of insulin from cystein inactivation
EP0717625A4 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ES8801841A1 (es) Procedimiento de obtencion de una composicion de copolimero octobloque biologicamente activo.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee